Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 16Withdrawn 2Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 39Genitourinary 23Thoracic 11Breast 10Other hematologic neoplasm 8Lymphoid 4Sarcoma 3Head & Neck 3Endocrine 3Tumor-Agnostic 2Plasma cell 2Myeloid 2Gynecologic 2CNS 2Other solid neoplasm 1Dermatologic 1Classical hematology 1

Conditions

Neurologic Manifestations 1Meningeal Carcinomatosis 1Gliosarcoma 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 80Radiotherapy 41Bevacizumab 35Radiosurgery 23Magnetic Resonance Spectroscopy 20Cyclophosphamide 17Radiation 14Irinotecan 13Carboplatin 12Topotecan 11Nivolumab 11Lomustine 11Filgrastim 10Everolimus 10Etoposide 10Erlotinib Hydrochloride 10pembrolizumab 9Radiotherapy, Intensity-Modulated 9Ipilimumab 9Granulocyte Colony-Stimulating Factor 8Carmustine 8antineoplaston AS 2-1 7antineoplaston A10 7Surgical Procedures, Operative 7Mental Status and Dementia Tests 7Isotretinoin 7Granulocyte-Macrophage Colony-Stimulating Factor 7sargramostim 6Vincristine 6TPI-287 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Sorafenib × CNS × Clear all
NCT00734526 2018-11-09

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

M.D. Anderson Cancer Center

Phase 1 Terminated
18 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Terminated
2 enrolled 6 charts
BreastCNS

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡